Advertisement

Plasma Biomarker for Alzheimer’s Disease: Are We Ready Now for Clinical Practice and Drug Trials?

  • A. Nakamura
Editorial
  • 12 Downloads

References

  1. 1.
    Henriksen K, O’Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, et al. The future of blood-based biomarkers for Alzheimer’s disease. Alzheimers Dement. 2014;10(1):115–31.CrossRefPubMedGoogle Scholar
  2. 2.
    O’Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement. 2016.Google Scholar
  3. 3.
    Wood H. Alzheimer disease: Biomarkers of AD risk-the end of the road for plasma amyloid-beta? Nat Rev Neurol. 2016;12(11):613.CrossRefPubMedGoogle Scholar
  4. 4.
    Fandos N, Perez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, et al. Plasma amyloid beta 42/40 ratios as biomarkers for amyloid beta cerebral deposition in cognitively normal individuals. Alzheimer’s & dementia (Amsterdam, Netherlands). 2017;8:179–87.PubMedCentralGoogle Scholar
  5. 5.
    Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, et al. Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 2017;13(8):841–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nabers A, Perna L, Lange J, Mons U, Schartner J, Güldenhaupt J, et al. Amyloid blood biomarker detects Alzheimer’s disease. EMBO Mol Med. 2018.Google Scholar
  7. 7.
    Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature. 2018;554(7691):249–54.CrossRefPubMedGoogle Scholar
  8. 8.
    Kaneko N, Nakamura A, Washimi Y, Kato T, Sakurai T, Arahata Y, et al. Novel plasma biomarker surrogating cerebral amyloid deposition. Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(9):353–64.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    O’Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research. Alzheimers Dement. 2015;11(5):549–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31(8):1275–83.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Center for Development of Advanced Medicine for DementiaNational Center for Geriatrics and GerontologyObu, AichiJapan

Personalised recommendations